Correction: Issue of Consideration SharesSource: RNS
This announcement amends and replaces the announcement "Issue of Consideration Shares" made by the Company on 2 September 2019 at 7:00am under RNS No: 7910K.
The previous announcement made reference to the issuance and allotment of 389,518 ordinary shares of 6 3/7 pence each as part of the consideration for the acquisition of RevStream Inc. This should have been 398,518 ordinary shares of 6 3/7 pence each. All other information remains unchanged. The amended announcement is set out in full below:
2 September 2019
Aptitude Software Group plc (the "Company")
Issue of Consideration Shares
Aptitude Software Group plc (LSE: APTD) announces that it has issued and allotted 398,518 ordinary shares of 6 3/7 pence each (the "New Ordinary Shares") as part of the consideration for the acquisition of RevStream Inc. ('RevStream'), as announced on 31 August 2017.
Application has therefore been made for the admission of the New Ordinary Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities ("Admission"). The New Ordinary Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 5 September 2019.
Following the allotment of the New Ordinary Shares, the Company's issued share capital comprises 63,589,342 ordinary shares of 6 3/7 pence each ("Ordinary Shares") with one voting right each. The Company does not hold any Ordinary Shares in treasury. Accordingly, Shareholders may use this figure as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Ordinary Shares in the Company under the FCA's Disclosure Guidance and Transparency Rules.
Georgina Sharley, Company Secretary 0203 880 7100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.